nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—Excitement—Indinavir—acquired immunodeficiency syndrome	0.0438	0.0438	CcSEcCtD
Pralidoxime—Inflammation—Amprenavir—acquired immunodeficiency syndrome	0.0346	0.0346	CcSEcCtD
Pralidoxime—Inflammation—Didanosine—acquired immunodeficiency syndrome	0.0316	0.0316	CcSEcCtD
Pralidoxime—Inflammation—Nevirapine—acquired immunodeficiency syndrome	0.0284	0.0284	CcSEcCtD
Pralidoxime—Inflammation—Nelfinavir—acquired immunodeficiency syndrome	0.0275	0.0275	CcSEcCtD
Pralidoxime—Inflammation—Stavudine—acquired immunodeficiency syndrome	0.0274	0.0274	CcSEcCtD
Pralidoxime—Inflammation—Abacavir—acquired immunodeficiency syndrome	0.027	0.027	CcSEcCtD
Pralidoxime—Inflammation—Indinavir—acquired immunodeficiency syndrome	0.0221	0.0221	CcSEcCtD
Pralidoxime—Inflammation—Efavirenz—acquired immunodeficiency syndrome	0.0209	0.0209	CcSEcCtD
Pralidoxime—Inflammation—Delavirdine—acquired immunodeficiency syndrome	0.02	0.02	CcSEcCtD
Pralidoxime—Inflammation—Saquinavir—acquired immunodeficiency syndrome	0.0178	0.0178	CcSEcCtD
Pralidoxime—Muscular weakness—Nelfinavir—acquired immunodeficiency syndrome	0.0171	0.0171	CcSEcCtD
Pralidoxime—Inflammation—Lamivudine—acquired immunodeficiency syndrome	0.017	0.017	CcSEcCtD
Pralidoxime—Muscular weakness—Abacavir—acquired immunodeficiency syndrome	0.0168	0.0168	CcSEcCtD
Pralidoxime—Diplopia—Efavirenz—acquired immunodeficiency syndrome	0.0147	0.0147	CcSEcCtD
Pralidoxime—Diplopia—Delavirdine—acquired immunodeficiency syndrome	0.0141	0.0141	CcSEcCtD
Pralidoxime—Muscular weakness—Indinavir—acquired immunodeficiency syndrome	0.0138	0.0138	CcSEcCtD
Pralidoxime—Haemoglobin—Nelfinavir—acquired immunodeficiency syndrome	0.0135	0.0135	CcSEcCtD
Pralidoxime—Haemorrhage—Nelfinavir—acquired immunodeficiency syndrome	0.0134	0.0134	CcSEcCtD
Pralidoxime—Diplopia—Ritonavir—acquired immunodeficiency syndrome	0.013	0.013	CcSEcCtD
Pralidoxime—Muscular weakness—Efavirenz—acquired immunodeficiency syndrome	0.013	0.013	CcSEcCtD
Pralidoxime—Muscular weakness—Delavirdine—acquired immunodeficiency syndrome	0.0124	0.0124	CcSEcCtD
Pralidoxime—Muscular weakness—Ritonavir—acquired immunodeficiency syndrome	0.0115	0.0115	CcSEcCtD
Pralidoxime—Drowsiness—Efavirenz—acquired immunodeficiency syndrome	0.0114	0.0114	CcSEcCtD
Pralidoxime—Muscular weakness—Saquinavir—acquired immunodeficiency syndrome	0.0111	0.0111	CcSEcCtD
Pralidoxime—Haemoglobin—Indinavir—acquired immunodeficiency syndrome	0.0108	0.0108	CcSEcCtD
Pralidoxime—Haemorrhage—Indinavir—acquired immunodeficiency syndrome	0.0108	0.0108	CcSEcCtD
Pralidoxime—Agitation—Nelfinavir—acquired immunodeficiency syndrome	0.0107	0.0107	CcSEcCtD
Pralidoxime—Muscular weakness—Lamivudine—acquired immunodeficiency syndrome	0.0106	0.0106	CcSEcCtD
Pralidoxime—Pain—Didanosine—acquired immunodeficiency syndrome	0.00934	0.00934	CcSEcCtD
Pralidoxime—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.00906	0.00906	CcSEcCtD
Pralidoxime—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.00902	0.00902	CcSEcCtD
Pralidoxime—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.00885	0.00885	CcSEcCtD
Pralidoxime—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.00873	0.00873	CcSEcCtD
Pralidoxime—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.00872	0.00872	CcSEcCtD
Pralidoxime—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.00868	0.00868	CcSEcCtD
Pralidoxime—Agitation—Indinavir—acquired immunodeficiency syndrome	0.00863	0.00863	CcSEcCtD
Pralidoxime—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00845	0.00845	CcSEcCtD
Pralidoxime—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.00843	0.00843	CcSEcCtD
Pralidoxime—Pain—Nevirapine—acquired immunodeficiency syndrome	0.0084	0.0084	CcSEcCtD
Pralidoxime—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.00836	0.00836	CcSEcCtD
Pralidoxime—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.00815	0.00815	CcSEcCtD
Pralidoxime—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00813	0.00813	CcSEcCtD
Pralidoxime—Pain—Stavudine—acquired immunodeficiency syndrome	0.00811	0.00811	CcSEcCtD
Pralidoxime—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.008	0.008	CcSEcCtD
Pralidoxime—Pain—Abacavir—acquired immunodeficiency syndrome	0.00799	0.00799	CcSEcCtD
Pralidoxime—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.0078	0.0078	CcSEcCtD
Pralidoxime—Headache—Amprenavir—acquired immunodeficiency syndrome	0.0075	0.0075	CcSEcCtD
Pralidoxime—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.0074	0.0074	CcSEcCtD
Pralidoxime—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00733	0.00733	CcSEcCtD
Pralidoxime—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00721	0.00721	CcSEcCtD
Pralidoxime—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00712	0.00712	CcSEcCtD
Pralidoxime—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00707	0.00707	CcSEcCtD
Pralidoxime—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00705	0.00705	CcSEcCtD
Pralidoxime—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.00694	0.00694	CcSEcCtD
Pralidoxime—Headache—Didanosine—acquired immunodeficiency syndrome	0.00684	0.00684	CcSEcCtD
Pralidoxime—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00681	0.00681	CcSEcCtD
Pralidoxime—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00676	0.00676	CcSEcCtD
Pralidoxime—Pain—Indinavir—acquired immunodeficiency syndrome	0.00655	0.00655	CcSEcCtD
Pralidoxime—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00649	0.00649	CcSEcCtD
Pralidoxime—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00644	0.00644	CcSEcCtD
Pralidoxime—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00629	0.00629	CcSEcCtD
Pralidoxime—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00627	0.00627	CcSEcCtD
Pralidoxime—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00625	0.00625	CcSEcCtD
Pralidoxime—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00619	0.00619	CcSEcCtD
Pralidoxime—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00618	0.00618	CcSEcCtD
Pralidoxime—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00616	0.00616	CcSEcCtD
Pralidoxime—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00615	0.00615	CcSEcCtD
Pralidoxime—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00596	0.00596	CcSEcCtD
Pralidoxime—Headache—Stavudine—acquired immunodeficiency syndrome	0.00594	0.00594	CcSEcCtD
Pralidoxime—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00592	0.00592	CcSEcCtD
Pralidoxime—Headache—Abacavir—acquired immunodeficiency syndrome	0.00585	0.00585	CcSEcCtD
Pralidoxime—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00583	0.00583	CcSEcCtD
Pralidoxime—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.0057	0.0057	CcSEcCtD
Pralidoxime—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00565	0.00565	CcSEcCtD
Pralidoxime—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00563	0.00563	CcSEcCtD
Pralidoxime—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00555	0.00555	CcSEcCtD
Pralidoxime—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00548	0.00548	CcSEcCtD
Pralidoxime—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00548	0.00548	CcSEcCtD
Pralidoxime—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00545	0.00545	CcSEcCtD
Pralidoxime—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00527	0.00527	CcSEcCtD
Pralidoxime—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00523	0.00523	CcSEcCtD
Pralidoxime—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00516	0.00516	CcSEcCtD
Pralidoxime—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00507	0.00507	CcSEcCtD
Pralidoxime—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00503	0.00503	CcSEcCtD
Pralidoxime—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.0049	0.0049	CcSEcCtD
Pralidoxime—Headache—Indinavir—acquired immunodeficiency syndrome	0.0048	0.0048	CcSEcCtD
Pralidoxime—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00479	0.00479	CcSEcCtD
Pralidoxime—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00458	0.00458	CcSEcCtD
Pralidoxime—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00455	0.00455	CcSEcCtD
Pralidoxime—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00454	0.00454	CcSEcCtD
Pralidoxime—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00434	0.00434	CcSEcCtD
Pralidoxime—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.0043	0.0043	CcSEcCtD
Pralidoxime—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00424	0.00424	CcSEcCtD
Pralidoxime—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00412	0.00412	CcSEcCtD
Pralidoxime—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00408	0.00408	CcSEcCtD
Pralidoxime—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00401	0.00401	CcSEcCtD
Pralidoxime—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00389	0.00389	CcSEcCtD
Pralidoxime—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00386	0.00386	CcSEcCtD
Pralidoxime—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00381	0.00381	CcSEcCtD
Pralidoxime—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00369	0.00369	CcSEcCtD
Pralidoxime—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00366	0.00366	CcSEcCtD
Pralidoxime—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00349	0.00349	CcSEcCtD
